510(k) Report

FDA product code · Hematology

Fibrinogen And Split Products, Rhodamine, Antigen, Antiserum, Control

DARClass II21 CFR 864.7340510(k) required0 decisions0 recalls

0 FDA decisions. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, hematology panel

Twenty years of DAR at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · DAR

FDA has decided no DAR device since 2007.

Median 510(k) review, days · DAR

Too few DAR 510(k)s in any year since 2007 to give a median.

Recalls per year · DAR

No recall names DAR since 2007.

Adverse event reports per year · DAR

1in 2025

2018: 12025: 1
2007high 1 (2018) · low 0 (2007)2025

MAUDE reports naming product code DAR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—01
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—01
20260—0—
FIG. 1 — DAR by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in DAR? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Related product codes

Other codes under 21 CFR 864.7340.